BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23642806)

  • 21. Relationship between delayed reactions to dermal fillers and biofilms: facts and considerations.
    Beer K; Avelar R
    Dermatol Surg; 2014 Nov; 40(11):1175-9. PubMed ID: 25207761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers.
    Christensen LH
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1612-9. PubMed ID: 19807755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cutaneous adverse reaction to Bio-Alcamid implant].
    Gómez-de la Fuente E; Alvarez-Fernández JG; Pinedo F; Naz E; Gamo R; Vicente-Martín FJ; López-Estebaranz JL
    Actas Dermosifiliogr; 2007 May; 98(4):271-5. PubMed ID: 17506960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foreign body granulomatous reactions to cosmetic fillers: a clinical study of 15 cases.
    Sanchis-Bielsa JM; Bagán JV; Poveda R; Salvador I
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Aug; 108(2):237-41. PubMed ID: 19615662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complications of fillers: overview.
    Duffy DM
    Dermatol Surg; 2005 Nov; 31(11 Pt 2):1626-33. PubMed ID: 16416648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin rejuvenation without a scalpel. I. Fillers.
    Haneke E
    J Cosmet Dermatol; 2006 Jun; 5(2):157-67. PubMed ID: 17173591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid.
    Arron ST; Neuhaus IM
    J Cosmet Dermatol; 2007 Sep; 6(3):167-71. PubMed ID: 17760694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The histological aspects of fillers complications.
    Zimmermann US; Clerici TJ
    Semin Cutan Med Surg; 2004 Dec; 23(4):241-50. PubMed ID: 15745233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dermal fillers: types, indications, and complications].
    Sánchez-Carpintero I; Candelas D; Ruiz-Rodríguez R
    Actas Dermosifiliogr; 2010 Jun; 101(5):381-93. PubMed ID: 20525480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tacrolimus in the treatment of chronic and refractory late-onset immune-mediated adverse effects related to silicone injections.
    Alijotas-Reig J; Garcia-Gimenez V; Vilardell-Tarrés M
    Dermatol Surg; 2012 Jan; 38(1):38-47. PubMed ID: 22122552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biocompatibility of microparticles into soft tissue fillers.
    Laeschke K
    Semin Cutan Med Surg; 2004 Dec; 23(4):214-7. PubMed ID: 15745227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of complications of injectable silicone.
    Hexsel D; de Morais MR
    Facial Plast Surg; 2014 Dec; 30(6):623-7. PubMed ID: 25536128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications of collagen fillers.
    Lucey P; Goldberg DJ
    Facial Plast Surg; 2014 Dec; 30(6):615-22. PubMed ID: 25536127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse reactions to injectable soft tissue fillers.
    Requena L; Requena C; Christensen L; Zimmermann US; Kutzner H; Cerroni L
    J Am Acad Dermatol; 2011 Jan; 64(1):1-34; quiz 35-6. PubMed ID: 21167403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A histologic study of adverse effects of different cosmetic skin fillers.
    Parada MB; Michalany NS; Hassun KM; Bagatin E; Talarico S
    Skinmed; 2005; 4(6):345-9. PubMed ID: 16276149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse reactions to facial dermal fillers: a case report.
    Kehily E; Hayes M; McCreary C
    J Ir Dent Assoc; 2015; 61(1):36-9. PubMed ID: 26281624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of dermal filler complications.
    Winslow CP
    Facial Plast Surg; 2009 May; 25(2):124-8. PubMed ID: 19415581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations.
    Smith KC
    Dermatol Online J; 2008 Aug; 14(8):3. PubMed ID: 19061563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium hydroxylapatite filler: an overview of safety and tolerability.
    Pavicic T
    J Drugs Dermatol; 2013 Sep; 12(9):996-1002. PubMed ID: 24002146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypersensitivity reactions associated with endovascular devices.
    Honari G; Ellis SG; Wilkoff BL; Aronica MA; Svensson LG; Taylor JS
    Contact Dermatitis; 2008 Jul; 59(1):7-22. PubMed ID: 18537993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.